To understand bone marrow failure and identify new treatments, detailed knowledge on how different types of blood cells are formed is essential. This work aimed to answer two fundamental questions: ‘What genes determine the proportion of specific cell types in the blood?’ and ‘What are the underlying genetic drivers for gene expression in different blood cells?’.
Over 1000 blood samples and 72 bone marrow samples from Tasmanians were subjected to in-depth analysis to gain a deeper understanding of how genetic differences between people affect the development of blood cells. Several publications have resulted from this work, helping to predict how genetic variants affect the severity of bone marrow failure and providing important information on potential new targets for treatment.
2023- 2025 (Fellowship): Discovery of novel niche factors to improve long-term stem cell transplantation in bone marrow failure syndromes. Dr Vashe Chandrakanthan, The University of Adelaide. For many patients with Bone Marrow Failure Syndromes, ...
Read more2022-2025 (Fellowship): Dissecting immune dysregulation in acquired Bone Marrow Failure Syndromes to identify new therapeutic leads. Associate Professor Rachel Koldej, ACRF Translational Research Laboratory, Melbourne Health. Bone Marrow Failure ...
Read more2023- 2025 (Fellowship): The inaugural Captain Courageous Fellowship. A preclinical trial of next generation gene editing for the prevention of bone marrow failure in Fanconi Anaemia. Dr Astrid Glaser at the Genome Stability Unit of St Vincent’s ...
Read more2019-2023 (Co-funded VCA/Maddie Riewoldt’s Vision International Travelling Fellowship): Novel immunological assessment of Aplastic Anaemia and post transplant Graft Dysfunction for the purposes of targeted therapeutic intervention. Dr ...
Read more